Thymidylate Synthase as Biomarker in Rectal Cancer Patients After 5-FU-based Radiochemotherapy - Evaluation of the Prognostic Capacity in Pre-treatment Biopsies and Resected Adenocarcinoma

2011 | conference abstract. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Thymidylate Synthase as Biomarker in Rectal Cancer Patients After 5-FU-based Radiochemotherapy - Evaluation of the Prognostic Capacity in Pre-treatment Biopsies and Resected Adenocarcinoma​
Conradi, L.-C. ; Bleckmann, A. ; Sprenger, T. ; Schirmer, M. A. ; Homayounfar, K. ; Wolff, H. A.   & Becker, H. et al.​ (2011)
European Journal of Cancer, 47 ​European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care​, Stockholm, SWEDEN.
Oxford​: Elsevier Sci Ltd.

Copy

Further links

Documents & Media

License

GRO License GRO License

Details

Authors
Conradi, Lena-Christin ; Bleckmann, Annalen ; Sprenger, Thilo ; Schirmer, Markus Anton ; Homayounfar, Kia ; Wolff, Hendrik Andreas ; Becker, H.; Ghadimi, Michael B. ; Beißbarth, Tim ; Liersch, Torsten 
Issue Date
2011
Status
published
Publisher
Elsevier Sci Ltd
Journal
European Journal of Cancer 
Conference
European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care
Conference Place
Stockholm, SWEDEN
ISSN
0959-8049
Extent
S430

Export Metadata

Refman EndNote BibTeX RefWorks Excel CSV

Reference

Citations